Suchen
Eikon Therapeutics Ord Shs
EIKNZur Watchlist hinzufügen
8.290USD
+0.160+1.97%
Handelsschluss 09-24 16:00（ET）
448.82MMarktkapitalisierung
VerlustKGV TTM
Über Eikon Therapeutics Ord Shs Unternehmen
Eikon Therapeutics Ord Shs Profil
BörsenkürzelEIKN
Name des UnternehmensEikon Therapeutics Inc
IPO-datumFeb 05, 2026
CEOPerlmutter (Roger M)
Anzahl der mitarbeiter384
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 05
Addresse230 Harriet Tubman Way
StadtMILLBRAE
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl94030
Telefon13026587581
Websitehttps://eikontx.com/
BörsenkürzelEIKN
IPO-datumFeb 05, 2026
CEOPerlmutter (Roger M)
Führungskräfte von Eikon Therapeutics Ord Shs
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Roger M. Perlmutter, M.D., Ph.D.
Dr. Roger M. Perlmutter, M.D., Ph.D.
Chairman of the Board, Chief Executive Officer, Director
Chairman of the Board, Chief Executive Officer, Director
1.48M
--
Dr. Roger M. Perlmutter, M.D., Ph.D.
Dr. Roger M. Perlmutter, M.D., Ph.D.
Chairman of the Board, Chief Executive Officer, Director
Chairman of the Board, Chief Executive Officer, Director
1.48M
--
Dr. Roger M. Perlmutter, M.D., Ph.D.
Dr. Roger M. Perlmutter, M.D., Ph.D.
Chairman of the Board, Chief Executive Officer, Director
Chairman of the Board, Chief Executive Officer, Director
1.48M
--
Mr. Kenneth C. Frazier
Mr. Kenneth C. Frazier
Independent Director
Independent Director
111.11K
+100.00%
Mr. Kenneth C. Frazier
Mr. Kenneth C. Frazier
Independent Director
Independent Director
111.11K
+100.00%
Mr. Kenneth C. Frazier
Mr. Kenneth C. Frazier
Independent Director
Independent Director
111.11K
+100.00%
Dr. Alfred Bowie, Ph.D.
Dr. Alfred Bowie, Ph.D.
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Roy D. Baynes, M.D., Ph.D.
Dr. Roy D. Baynes, M.D., Ph.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
-100.00%
Mr. Michael A. Klobuchar
Mr. Michael A. Klobuchar
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Benjamin Thorner
Mr. Benjamin Thorner
Chief Business Officer, General Counsel
Chief Business Officer, General Counsel
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Roger M. Perlmutter, M.D., Ph.D.
Dr. Roger M. Perlmutter, M.D., Ph.D.
Chairman of the Board, Chief Executive Officer, Director
Chairman of the Board, Chief Executive Officer, Director
1.48M
--
Dr. Roger M. Perlmutter, M.D., Ph.D.
Dr. Roger M. Perlmutter, M.D., Ph.D.
Chairman of the Board, Chief Executive Officer, Director
Chairman of the Board, Chief Executive Officer, Director
1.48M
--
Dr. Roger M. Perlmutter, M.D., Ph.D.
Dr. Roger M. Perlmutter, M.D., Ph.D.
Chairman of the Board, Chief Executive Officer, Director
Chairman of the Board, Chief Executive Officer, Director
1.48M
--
Mr. Kenneth C. Frazier
Mr. Kenneth C. Frazier
Independent Director
Independent Director
111.11K
+100.00%
Mr. Kenneth C. Frazier
Mr. Kenneth C. Frazier
Independent Director
Independent Director
111.11K
+100.00%
Mr. Kenneth C. Frazier
Mr. Kenneth C. Frazier
Independent Director
Independent Director
111.11K
+100.00%
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Eikon Therapeutics Ord Shs?
Die fünf größten Anteilseigner von Eikon Therapeutics Ord Shs sind: Dr. Roger M. Perlmutter, M.D., Ph.D.